Details for Patent: 7,504,095
✉ Email this page to a colleague
Which drugs does patent 7,504,095 protect, and when does it expire?
Patent 7,504,095 protects NULIBRY and is included in one NDA.
This patent has ten patent family members in ten countries.
Summary for Patent: 7,504,095
| Title: | Method for obtaining precursor Z and use thereof for the production of a means for therapy of human molybdenum cofactor deficiency |
| Abstract: | The invention relates to a method for obtaining the molybdopterin derivative precursor Z, wherein an over-production of precursor Z occurs in host organisms by recombinant expression of precursor Z synthesizing proteins. The invention further relates to the use of precursor Z for the production of a means for the therapy of human molybdenum cofactor deficiency and associated diseases, which may be directly or indirectly attributed to an altered molybdenum cofactor synthesis, whereby precursor Z is used as essential component of said therapy means. |
| Inventor(s): | Schwarz; Guenter (Niederkassel, DE), Mendel; Ralf (Leitferde, DE), Santamaria; Jose (Koln, DE), Reiss; Jochen (Niemetal, DE) |
| Assignee: | Technische Universitaet Braunschweig (Braunschweig, DE) |
| Application Number: | 11/343,489 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Compound; |
Drugs Protected by US Patent 7,504,095
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sentynl Theraps Inc | NULIBRY | fosdenopterin hydrobromide | POWDER;INTRAVENOUS | 214018-001 | Feb 26, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | METHOD OF TREATING MOLYBDENUM COFACTOR DEFICIENCY TYPE A | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,504,095
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Germany | 10 2004 004 642 | Jan 29, 2004 |
| Germany | 10 2004 063 948 | Jan 30, 2004 |
International Family Members for US Patent 7,504,095
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2554461 | ⤷ Try a Trial | |||
| Cyprus | 1113960 | ⤷ Try a Trial | |||
| Germany | 102004004642 | ⤷ Try a Trial | |||
| Denmark | 1664317 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
